Shareholders' Equity | Shareholders' Equity The following tables present a reconciliation of changes in stockholders' equity for the three and nine months ended June 30, 2020 and 2019 . Common stock Additional Accumulated Retained Total Number of Stated (In thousands, except share and per share data) Balance, September 30, 2019 119,338,925 $ 597 $ 3,712,194 $ (114,583 ) $ 2,152,015 $ 5,750,223 Net income — — — — 178,673 178,673 Other comprehensive income — — — 1,052 — 1,052 Cash dividends ($0.575 per share) — — — — (69,557 ) (69,557 ) Common stock issued: Public and other stock offerings 2,758,929 13 263,259 — — 263,272 Stock-based compensation plans 164,549 1 4,111 — — 4,112 Balance, December 31, 2019 122,262,403 611 3,979,564 (113,531 ) 2,261,131 6,127,775 Net income — — — — 239,646 239,646 Other comprehensive income — — — 890 — 890 Cash dividends ($0.575 per share) — — — — (70,520 ) (70,520 ) Common stock issued: Public and other stock offerings 38,662 1 3,095 — — 3,096 Stock-based compensation plans 7,660 — 3,528 — — 3,528 Balance, March 31, 2020 122,308,725 612 3,986,187 (112,641 ) 2,430,257 6,304,415 Net income — — — — 117,791 117,791 Other comprehensive loss — — — (4,086 ) — (4,086 ) Cash dividends ($0.575 per share) — — — — (70,597 ) (70,597 ) Common stock issued: Public and other stock offerings 965,576 5 105,799 — — 105,804 Stock-based compensation plans 76,966 — 8,144 — — 8,144 Balance, June 30, 2020 123,351,267 $ 617 $ 4,100,130 $ (116,727 ) $ 2,477,451 $ 6,461,471 Common stock Additional Accumulated Retained Total Number of Stated (In thousands, except share and per share data) Balance, September 30, 2018 111,273,683 $ 556 $ 2,974,926 $ (83,647 ) $ 1,878,116 $ 4,769,951 Net income — — — — 157,646 157,646 Other comprehensive loss — — — (22,258 ) — (22,258 ) Cash dividends ($0.525 per share) — — — — (58,722 ) (58,722 ) Cumulative effect of accounting change — — — (8,210 ) 8,210 — Common stock issued: Public and other stock offerings 5,434,812 27 498,948 — — 498,975 Stock-based compensation plans 184,464 1 2,602 — — 2,603 Balance, December 31, 2018 116,892,959 584 3,476,476 (114,115 ) 1,985,250 5,348,195 Net income — — — — 214,888 214,888 Other comprehensive loss — — — (2,695 ) — (2,695 ) Cash dividends ($0.525 per share) — — — — (61,606 ) (61,606 ) Common stock issued: Public and other stock offerings 61,006 1 5,453 — — 5,454 Stock-based compensation plans 28,938 — 3,865 — — 3,865 Balance, March 31, 2019 116,982,903 585 3,485,794 (116,810 ) 2,138,532 5,508,101 Net income — — — — 80,466 80,466 Other comprehensive income — — — 1,147 — 1,147 Cash dividends ($0.525 per share) — — — — (61,654 ) (61,654 ) Common stock issued: Public and other stock offerings 1,127,244 5 103,425 — — 103,430 Stock-based compensation plans 85,966 1 10,505 — — 10,506 Balance, June 30, 2019 118,196,113 $ 591 $ 3,599,724 $ (115,663 ) $ 2,157,344 $ 5,641,996 Shelf Registration, At-the-Market Equity Sales Program and Equity Issuances On February 11, 2020, we filed a shelf registration statement with the Securities and Exchange Commission (SEC) that allows us to issue up to $4.0 billion in common stock and/or debt securities, which expires February 11, 2023. This shelf registration statement replaced our previous shelf registration statement which was filed on November 13, 2018 (2018 Registration Statement). At June 30, 2020 , approximately $3.0 billion of securities remained available for issuance under the shelf registration statement. On February 12, 2020, we filed a prospectus supplement under the shelf registration statement relating to an at-the-market (ATM) equity sales program (February 2020 ATM) under which we may issue and sell shares of our common stock up to an aggregate offering price of $1.0 billion (including shares of common stock that may be sold pursuant to forward sale agreements entered into concurrently with the ATM equity sales program). This ATM equity sales program replaced our previous ATM equity sales program, filed on November 19, 2018 (November 2018 ATM), which was exhausted during the second quarter of fiscal 2020 with the execution of forward sales. During the nine months ended June 30, 2020 , we executed forward sales under the February 2020 ATM and the November 2018 ATM equity sales programs with various forward sellers who borrowed and sold 4,148,057 shares of our common stock at an aggregate price of $453.9 million . Additionally, during the nine months ended June 30, 2020 , we settled forward sale agreements with respect to 3,146,108 shares that had been borrowed and sold by various forward sellers during fiscal 2019 under the November 2018 ATM for net proceeds of $314.6 million . As of June 30, 2020 , the February 2020 ATM program had approximately $621 million of equity available for issuance. On November 30, 2018, we filed a prospectus supplement under the 2018 Registration Statement relating to an underwriting agreement to sell 5,390,836 shares of our common stock for $500 million . After expenses, net proceeds from the offering were $494.1 million . Concurrently, we entered into separate forward sales agreements with two forward sellers who borrowed and sold 2,668,464 shares of our common stock at an aggregate price of $247.5 million . During the nine months ended June 30, 2019, we settled forward sale agreements with respect to 1,089,700 of the shares that had been borrowed and sold for net proceeds of $99.6 million . During the nine months ended June 30, 2020 , we settled the remaining 485,189 shares under these forward sale agreements for net proceeds of $44.4 million . During the nine months ended June 30, 2019, we executed forward sales under the November 2018 ATM with various forward sellers who borrowed and sold 2,721,072 shares of our common stock at an aggregate price of $268.7 million . If we had settled all shares that remain available under our outstanding forward sale agreements as of June 30, 2020 , we would have received proceeds of $547.2 million , based on a net price of $106.33 per share. Additional details are presented below. Maturity Shares Available Net Proceeds Available Forward Price September 30, 2020 1,662,270 $ 174,142 $ 104.76 March 31, 2021 2,089,927 229,650 $ 109.88 June 30, 2021 1,394,423 143,430 $ 102.86 Total 5,146,620 $ 547,222 Accumulated Other Comprehensive Income (Loss) We record deferred gains (losses) in AOCI related to available-for-sale debt securities and interest rate agreement cash flow hedges. Deferred gains (losses) for our available-for-sale debt securities are recognized in earnings upon settlement, while deferred gains (losses) related to our interest rate agreement cash flow hedges are recognized in earnings as they are amortized. The following tables provide the components of our accumulated other comprehensive income (loss) balances, net of the related tax effects allocated to each component of other comprehensive income (loss). Available- for-Sale Securities Interest Rate Agreement Cash Flow Hedges Total (In thousands) September 30, 2019 $ 132 $ (114,715 ) $ (114,583 ) Other comprehensive income (loss) before reclassifications 202 (4,932 ) (4,730 ) Amounts reclassified from accumulated other comprehensive income (2 ) 2,588 2,586 Net current-period other comprehensive income (loss) 200 (2,344 ) (2,144 ) June 30, 2020 $ 332 $ (117,059 ) $ (116,727 ) Available- for-Sale Securities Interest Rate Agreement Cash Flow Hedges Total (In thousands) September 30, 2018 $ 8,124 $ (91,771 ) $ (83,647 ) Other comprehensive income (loss) before reclassifications 192 (25,966 ) (25,774 ) Amounts reclassified from accumulated other comprehensive income (1 ) 1,969 1,968 Net current-period other comprehensive income (loss) 191 (23,997 ) (23,806 ) Cumulative effect of accounting change (8,210 ) — (8,210 ) June 30, 2019 $ 105 $ (115,768 ) $ (115,663 ) |